Airway response to low-dose allergen exposure in allergic nonasthmatic and asthmatic subjects: eosinophils, fibronectin, and vascular endothelial growth factor.
Boulay
Marie-Eve
ME
Centre de Recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Ste-Foy, Quebec, Canada. marie.eve.boulay@crhl.ulaval.ca
Boulet
Louis-Philippe
LP
D000485:Allergens / Q000008:administration & dosage* / Q000276:immunology / Q000494:pharmacology*; D001249:Asthma / Q000150:complications / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D016228:Endothelial Growth Factors / Q000276:immunology; D004804:Eosinophils / Q000187:drug effects / Q000276:immunology; D005353:Fibronectins / Q000187:drug effects / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000150:complications / Q000276:immunology*; D036341:Intercellular Signaling Peptides and Proteins / Q000276:immunology; D008222:Lymphokines / Q000187:drug effects / Q000276:immunology; D012137:Respiratory System / Q000187:drug effects* / Q000276:immunology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000485:Allergens; D016228:Endothelial Growth Factors; D005353:Fibronectins; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors